Physician profile
Chris Deaton
NPI 1578914925
$2,294.38
in general payments reported to CMS, 2019-2025
19 companies · $61.95 in 2025
The $61.95 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $168 · 2021: $212 · 2022: $447 · 2023: $498 · 2024: $354 · 2025: $61.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790 · Entertainment: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.38 |
| Entertainment | $122.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $456.17 | 2019-2024 | Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $308.34 | 2022-2025 | Infuse, Xiidra, Vyzulta |
| Johnson & Johnson Vision Care, INC. | $306.19 | 2020-2024 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $269.49 | 2019-2021 | |
| Rxsight INC | $146.06 | 2023 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Coopervision INC. | $137.47 | 2019-2020 | |
| Lkc Technologies, INC. | $129.28 | 2022 | |
| Optos, INC. | $122.91 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $85.57 | 2019-2022 | |
| Oyster Point Pharma, INC. | $65.82 | 2022-2024 | Tyrvaya, Ryzumvi |
| Eyevance Pharmaceuticals LLC | $49.68 | 2022 | |
| Novartis Pharmaceuticals Corporation | $45.97 | 2023 | |
| Sun Pharmaceutical Industries INC. | $41.77 | 2019-2022 | |
| Shire North American Group INC | $35.75 | 2019 | |
| Abbvie INC. | $26.01 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.26 | 2021 | |
| Tearlab Corp | $18.04 | 2019 | |
| Thea Pharma INC. | $15.65 | 2022 | |
| Harrow Eye, LLC | $14.95 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Deaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.